PF-114, A NOVEL SELECTIVE PAN BCR/ ABL INHIBITOR FOR PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIA, EFFECTIVELY TARGETS T315I AND THE OTHER RESISTANCE MUTANTS

被引：0
|
作者：
Mian, A. [1 ]
Badura, S. [1 ]
Rafiei, A. [1 ]
Metodieva, A. [1 ]
Zeifman, A. [2 ]
Titov, I. [2 ]
Stroylov, V. [2 ]
Stroganov, O. [2 ]
Novikov, F. [3 ]
Ottmann, O. [1 ]
Chilov, G. [2 ]
Ruthardt, M. [1 ]
机构：
[1] Goethe Univ, Hematol, Frankfurt, Germany
[2] Fus Pharma LLC, Moscow, Russia
[3] Fus Pharma LLC, Moscow, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1177
引用
收藏
页码：488 / 489
页数：2
相关论文
共 37 条
  • [31] MK-0457, a novel multikinase inhibitor, is active in patients with chronic myeloid leukemia (CML) and acute lymphocytic leukemia (ALL) with the T315I BCR-ABL resistance mutation and patients with refractory JAK-2 positive myeloproliferative diseases (MPD)
    Giles, J.
    Cortes, J.
    Bergstrom, D. A.
    Xiao, A.
    Jones, D.
    Verstovsek, S.
    Thomas, D.
    Rizzieri, D.
    Freedman, S. J.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 347 - 347
  • [32] AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in Imatinib-resistant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoid leukemia (Ph plus ALL).
    Kantarjian, HM
    Ottman, O
    Cortes, J
    Wassman, M
    Wunderle, L
    Bhalla, K
    Jones, D
    Hochhaus, A
    Rae, P
    Alland, L
    Dugan, M
    Albitar, M
    Giles, F
    BLOOD, 2005, 106 (11) : 15A - 16A
  • [33] AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in imatinib-resistant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoid leukemia (Ph plus ALL)
    Kantarjian, HM
    Ottmann, O
    Hochhaus, A
    Mueller, M
    Cortes, J
    Wassmann, B
    Wunderle, L
    Bhalla, K
    Jones, D
    Rafferty, T
    Albitar, M
    Rae, L
    Dugan, M
    Alland, L
    Giles, F
    ANNALS OF ONCOLOGY, 2006, 17 : 32 - 32
  • [34] Preliminary activity of AMN107, a novel potent oral selective Bcr-Abl tyrosine kinase inhibitor, in newly diagnosed Philadelphia chromosome (Ph)-positive chronic phase chronic myelogenous leukemia (CML-CP).
    Jabbour, E.
    Giles, F.
    Cortes, J.
    O'Brien, S.
    Ravandi, F.
    Borthakur, G.
    Garcia-Manero, G.
    Letvak, L.
    Salvado, A.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 358S - 358S
  • [35] Preliminary activity of nilotinib (AMN107), a novel selective potent oral Bcr-Abl tyrosine kinase inhibitor, in newly diagnosed Philadelphia chromosome (Ph)-positive chronic phase chronic myelogenous leukemia (CML-CP).
    Jabbour, Elias
    Cortes, Jorge
    Giles, Francis
    O'Brien, Susan
    Letvak, Laurie
    Kantarjian, Hagop
    BLOOD, 2006, 108 (11) : 616A - 616A
  • [36] With up to 8 Years of Therapy, Asciminib (ASC) Monotherapy Demonstrated Continued Favorable Efficacy, Safety, and Tolerability in Patients (Pts) with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph plus CML-CP) without the T315I Mutation: Final Results from the Phase 1 X2101 Study
    Hochhaus, Andreas
    Kim, Dong-Wook
    Cortes, Jorge
    Sasaki, Koji
    Mauro, Michael
    Hughes, Timothy P.
    Breccia, Massimo
    Talpaz, Moshe
    Minami, Hironobu
    Goh, Yeow Tee
    DeAngelo, Daniel J.
    Lang, Fabian
    Heinrich, Michael C.
    De Soria, Valle Gomez G.
    le Coutre, Philipp
    Sanchez-Olle, Gessami
    Jose, Jomy
    Pognan, Nathalie
    Kapoor, Shruti
    Rea, Delphine
    BLOOD, 2023, 142
  • [37] An Update of Safety and Efficacy Results oiii Phase 1 Dose-Escalation and Expansion Study of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI), in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Failing Prior TKI Therapies
    Cortes, Jorge E.
    Saikia, Tapan
    Kim, Dong-Wook
    Alvarado, Yesid
    Nicolini, Franck E.
    Rathnam, Krishnakumar
    Khattry, Navin
    Apperley, Jane F.
    Deininger, Michael W.
    de Lavallade, Hugues
    Charbonnier, Aude
    Granacher, Nikki
    Gambacorti-Passerini, Carlo
    Lucchesi, Alessandro
    Mauro, Michael J.
    Vandenberghe, Peter
    Verhoef, Gregor
    Whiteley, Andrew R.
    Nag, Arijit
    Radhakrishnan, Vivek S.
    Apte, Shashikant
    Yao, Siu-Long
    Inamdar, Sandeep
    Sreenivasan, Jayasree
    Dillu, Ruchika Irene
    Chimote, Geetanjali
    BLOOD, 2021, 138
1234